4-phenyl-3-furoxancarbonitrile has been researched along with oxadiazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Stilo, A; Ermondi, G; Ferretti, C; Fruttero, R; Gasco, A; Medana, C | 1 |
| Chen, Z; Chiou, GC; Liu, SX; Varma, RS; Xuan, BO | 1 |
| Bixler, H; Bizzozero, OA; Parkhani, J; Pastuszyn, A | 1 |
3 other study(ies) available for 4-phenyl-3-furoxancarbonitrile and oxadiazoles
| Article | Year |
|---|---|
Furoxans as nitric oxide donors. 4-Phenyl-3-furoxancarbonitrile: thiol-mediated nitric oxide release and biological evaluation.
Topics: Animals; Aorta, Thoracic; Enzyme Activation; Guanosine Monophosphate; Guanylate Cyclase; Humans; Lung; Male; Mass Spectrometry; Nitric Oxide; Norepinephrine; Oxadiazoles; Phenols; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Sulfhydryl Compounds; Vasodilation; Vasodilator Agents | 1994 |
Nitric oxide donors: effects of S-nitrosoglutathione and 4-phenyl-3-furoxancarbonitrile on ocular blood flow and retinal function recovery.
Topics: Animals; Electroretinography; Eye; Female; Glutathione; Nitric Oxide; Nitroso Compounds; Ocular Hypertension; Oxadiazoles; Rabbits; Rats; Retina; Retinal Artery; S-Nitrosoglutathione; Vasodilator Agents | 1997 |
Nitric oxide reduces the palmitoylation of rat myelin proteolipid protein by an indirect mechanism.
Topics: Acylation; Adenosine Triphosphate; Analysis of Variance; Animals; Brain; Cyclic N-Oxides; Female; Free Radical Scavengers; Imidazoles; Kinetics; Male; Myelin Proteolipid Protein; Nitric Oxide Donors; Nitro Compounds; Oxadiazoles; Palmitic Acid; Radioisotope Dilution Technique; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Tritium; Vasodilator Agents | 2001 |